| For Practicing Rheumatologists |
  See all
 | Articles: Clinical Pharmacology |
Celecoxib's CV risk is based partly on dose and schedule
Rheumatology News, 06/17/08
Methotrexate improves quality of life in JIA
Rheumatology News, 06/17/08
Immunogenicity differs in abatacept, infliximab
Rheumatology News, 06/17/08
Sustained benefits seen with biologics in PsA
Rheumatology News, 06/17/08
Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis
Modern Rheumatology, 06/17/08
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
Bone , 06/17/08
AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast
Bone , 06/17/08
Third Biologic Gets FDA Nod for Treating JIA
Rheumatology News, 06/16/08
Study: Bazedoxifene Prevents Postmenopausal Osteoporosis
Rheumatology News, 06/16/08
Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine
Joint, Bone, Spine, 06/16/08
|
|
Receive daily email updates on Clinical Pharmacology
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
